* Denotes Required Fields


Reglan (Metoclopramide) Tardive Dyskinesia Victims

The Law Firm of Eric H. Weinberg currently represents individuals injured by the dangerous side effects of well known prescription drugs.  We are ready to help you. If you believe that you have developed tardive dyskinesia or an involuatary movement disorder as a result of taking Reglan, please submit a Free Case Evaluation Form or call us toll free at 1-877-934-6274.  We pledge to bring our more than 20 years of experience litigating pharmaceutical cases to bear on your behalf.

FDA Warns That Reglan Increases Risk For Tardive Dyskinesia

As of February 26, 2009, the FDA has required labeling for Reglan and all metoclopramide-containing drugs to include a “Boxed Warning,” alerting doctors and patients of the increased risk of developing tardive dyskinesia.  A Boxed Warning (often referred to as a Black Box Warning) is the strongest warning that the FDA can require a prescription drug to include in its labeling.

The risk for developing Reglan-associated tardive dyskinesia is increased in the elderly (particularly women) and in those patients who have been using the drug for a long period of time.  According to the FDA, the development of tardive dyskinesia is directly related to the length of time that Reglan in used and number Reglan doses administered.

The FDA reports that recent analyses of available data suggest that metoclopramide is the most common cause of drug-induced movement disorders.  Further analysis of data by the FDA indicated that 20 of the study patients who had used metoclopramide took it for longer than three months.

Reglan And Metoclopramide Therapy

Reglan belongs to a class of drugs know as dopamine receptor antagonists, and works by increasing stomach emptying (into the upper intestines) and movement of the upper intestines.

Reglan (metoclopramide) is prescribed for the treatment of gastroesophageal reflux disease, and for the relief of symptoms associated with diabetic gastroparesis including nausea, vomiting, heartburn, persistent fullness after meals, and anorexia.

Reglan has also been prescribed for “off-label” or “unapproved” uses for the treatment of nausea and vomiting due to migraines, morning sickness, and gastroparesis due to other causes; and in infants for the treatment infant GERD.

Metoclopromide-containing products are available as multiple formulations including Reglan Tablets, Reglan Oral Disintegrating Tablets, Metoclopramide Oral Solution, and Reglan Injection.

Symptoms Of Tardive Dyskinesia

Tardive dyskinesia is characterized by involuntary, repetitive movements of the extremities or face (including grimacing, tongue protrusion, lip smacking, puckering and pursing of the lips, and rapid eye blinking) or impaired movements of the fingers. The symptoms are rarely reversible, and there is no known treatment. However, in some patients symptoms may lessen or resolve after metoclopramide therapy is discontinued.

What You Can Do If You Suspect You Are Experiencing Reglan Side Effects

Patients should contact their healthcare professional if they experience tardive dyskinesia-like symptoms associated with Reglan use or have questions regarding Reglan therapy.  Both consumers and healthcare professionals can report suspected Reglan (metoclopramide) side effects or product quality problems to the FDA’s MedWatch Adverse Event Reporting program at www.fda.gov/MedWatch/report.htm, or by phone 800-FDA-1088.

If you were injured as a result of Reglan use, please submit a Free Case Evaluation Form, or call us toll free at 1-877-934-6274.
Since 1984, the Law Firm of Eric H. Weinberg has represented hundreds of injured individuals including those injured by dangerous and defective drug and medical device products.  The firm has played a leading role in the litigation of high-profile drug lawsuits including Vioxx, Baycol, and blood products, recovering over $750 million on behalf of the firm's clients.